These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29292538)

  • 1. Outcomes of standardised approach to metabolic bone disease of prematurity.
    Chin LK; Doan J; Teoh YS; Stewart A; Forrest P; Simm PJ
    J Paediatr Child Health; 2018 Jun; 54(6):665-670. PubMed ID: 29292538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Bone Disease of Prematurity: Risk Factors and Associated Short-Term Outcomes.
    Avila-Alvarez A; Urisarri A; Fuentes-Carballal J; Mandiá N; Sucasas-Alonso A; Couce ML
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33321828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of metabolic bone disease in preterm infants of birth weight <1250 g and in those suffering from bronchopulmonary dysplasia.
    Gaio P; Verlato G; Daverio M; Cavicchiolo ME; Nardo D; Pasinato A; de Terlizzi F; Baraldi E
    Clin Nutr ESPEN; 2018 Feb; 23():234-239. PubMed ID: 29460805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteopenia of prematurity--prophylaxis, diagnostics and treatment].
    Hitrova S; Slancheva B; Popivanova A; Vakrilova L; Pramatarova T; Emilova Z; Yarakova N
    Akush Ginekol (Sofiia); 2012; 51(7):24-30. PubMed ID: 23610914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolic Bone Disease of Prematurity in Very Low Birthweight Infants: Retrospective Observational Study].
    Costa R; Franco C; Santos N; Maio P; Vieira F; Antunes S; Martins L; Tuna ML
    Acta Med Port; 2019 Aug; 32(7-8):536-541. PubMed ID: 31445534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic bone disease of prematurity and secondary hyperparathyroidism.
    Lothe A; Sinn J; Stone M
    J Paediatr Child Health; 2011 Aug; 47(8):550-3. PubMed ID: 21392146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound for the assessment of bone quality in preterm and term infants.
    Rack B; Lochmüller EM; Janni W; Lipowsky G; Engelsberger I; Friese K; Küster H
    J Perinatol; 2012 Mar; 32(3):218-26. PubMed ID: 21681177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors and biochemical markers in metabolic bone disease of premature newborns].
    Montaner Ramón A; Fernández Espuelas C; Calmarza Calmarza P; Rite Gracia S; Oliván Del Cacho MJ
    Rev Chil Pediatr; 2017; 88(4):487-494. PubMed ID: 28898316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic bone disease: a continued challenge in extremely low birth weight infants.
    Viswanathan S; Khasawneh W; McNelis K; Dykstra C; Amstadt R; Super DM; Groh-Wargo S; Kumar D
    JPEN J Parenter Enteral Nutr; 2014 Nov; 38(8):982-90. PubMed ID: 23963689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone Mineral Density According to Dual Energy X-ray Absorptiometry is Associated with Serial Serum Alkaline Phosphatase Level in Extremely Low Birth Weight Infants at Discharge.
    Lee J; Park HK; Kim JH; Choi YY; Lee HJ
    Pediatr Neonatol; 2017 Jun; 58(3):251-257. PubMed ID: 27780689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of calcium and phosphorus supplementation on metabolic bone disorders in premature infants.
    Torabi Z; Moemeni N; Ahmadiafshar A; Mazloomzadeh S
    J Pak Med Assoc; 2014 Jun; 64(6):635-9. PubMed ID: 25252480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypophosphatemia as an Early Metabolic Bone Disease Marker in Extremely Low-Birth-Weight Infants After Prolonged Parenteral Nutrition Exposure.
    Tan YL; Tsao PN; Chou HC; Yen TA; Chen CY
    JPEN J Parenter Enteral Nutr; 2021 Aug; 45(6):1268-1274. PubMed ID: 32860429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MOnitored supplementation of VItamin D in preterm infants (MOSVID trial): study protocol for a randomised controlled trial.
    Kołodziejczyk A; Borszewska-Kornacka MK; Seliga-Siwecka J
    Trials; 2017 Sep; 18(1):424. PubMed ID: 28893306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors analysis and prevention of metabolic bone disease of prematurity.
    Chen W; Yang C; Chen H; Zhang B
    Medicine (Baltimore); 2018 Oct; 97(42):e12861. PubMed ID: 30334994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of metabolic bone disease of prematurity.
    Ukarapong S; Venkatarayappa SKB; Navarrete C; Berkovitz G
    Early Hum Dev; 2017 Sep; 112():29-34. PubMed ID: 28683339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high prevalence of metabolic bone disease in exclusively breastfed very low birthweight infants in Dar-es-Salaam, Tanzania.
    Msomekela M; Manji K; Mbise RL; Kazema R; Makwaya C
    Ann Trop Paediatr; 1999 Dec; 19(4):337-44. PubMed ID: 10716027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is additional oral phosphate supplementation for preterm infants necessary: an assessment of clinical audit.
    Watts S; Mactier H; Grant J; Cameron Nicol E; Mullen AB
    Eur J Pediatr; 2013 Oct; 172(10):1313-9. PubMed ID: 23703467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineral status of premature infants in early life and linear growth at age 3.
    Isojima T; Kushima R; Goishi K; Tsuchida S; Watanabe T; Takahashi N; Kitanaka S
    Pediatr Int; 2015 Oct; 57(5):864-9. PubMed ID: 25865080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled evaluation of two commercially available human breast milk fortifiers in healthy preterm neonates.
    Sankaran K; Papageorgiou A; Ninan A; Sankaran R
    J Am Diet Assoc; 1996 Nov; 96(11):1145-9. PubMed ID: 8906139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative ultrasound (QUS): a useful tool for monitoring bone health in preterm infants?
    Fewtrell MS; Loh KL; Chomtho S; Kennedy K; Hawdon J; Khakoo A
    Acta Paediatr; 2008 Dec; 97(12):1625-30. PubMed ID: 19054850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.